Athira Pharma's total assets for Q4 2024 were $58.78M, a decrease of -31.85% from the previous quarter. ATHA total liabilities were $13.94M for the fiscal quarter, a -51.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.